1.5 References
1. Wright, P. E., & Dyson, H. J. (2015). Intrinsically disordered proteins in cellular signalling and regulation. Nature reviews Molecular cell biology, 16(1), 18-29.
2. Uversky, V. N. (2014). Intrinsically disordered proteins. In Intrinsically Disordered Proteins (pp. 1-51). Springer, Cham.
3. Dobson, C. M. (2003). Protein folding and misfolding. Nature, 426(6968), 884-890.
4. Dobson, C. M., Šali, A., & Karplus, M. (1998). Protein folding: a perspective from theory and experiment. Angewandte Chemie International Edition, 37(7), 868-893.
5. Wolynes, P. G., Onuchic, J. N., & Thirumalai, D. (1995). Navigating the folding routes. Science-AAAS-Weekly Paper Edition, 267(5204), 1619-1620.
6. Dill, K. A., & Chan, H. S. (1997). From Levinthal to pathways to funnels. Nature structural biology, 4(1), 10-19.
7. Dunker, A. K., Babu, M. M., Barbar, E., Blackledge, M., Bondos, S. E., Dosztányi, Z., ... & Han, K. H. (2013). What’s in a name? Why these proteins are intrinsically disordered: Why these proteins are intrinsically disordered. Intrinsically disordered proteins, 1(1), e24157.
8. Wright, P. E., & Dyson, H. J. (2009). Linking folding and binding. Current opinion in structural biology, 19(1), 31-38.
9. Uversky, V. N., Gillespie, J. R., & Fink, A. L. (2000). Why are “natively unfolded” proteins unstructured under physiologic conditions?. Proteins: structure, function, and bioinformatics, 41(3), 415-427.
10. Romero, P., Obradovic, Z., Li, X., Garner, E. C., Brown, C. J., & Dunker, A. K. (2001). Sequence complexity of disordered protein. Proteins: Structure, Function, and Bioinformatics, 42(1), 38-48.
11. Weathers, E. A., Paulaitis, M. E., Woolf, T. B., & Hoh, J. H. (2004). Reduced amino acid alphabet is sufficient to accurately recognize intrinsically disordered protein. FEBS letters, 576(3), 348-352.
12. Babu, M. M. (2016). The contribution of intrinsically disordered regions to protein function, cellular complexity, and human disease. Biochemical Society Transactions, 44(5), 1185-1200.
13. Ward, J.J., Sodhi, J.S., McGuffin, L.J., Buxton, B.F. and Jones, D.T., 2004. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. Journal of molecular biology, 337(3), pp.635-645.
14. Romero, P., Obradovic, Z., & Dunker, A. K. (2004). Natively disordered proteins. Applied bioinformatics, 3(2-3), 105-113.
15. Van Der Lee, R., Buljan, M., Lang, B., Weatheritt, R. J., Daughdrill, G. W., Dunker, A. K., ... & Kim, P. M. (2014). Classification of intrinsically disordered regions and proteins. Chemical reviews, 114(13), 6589-6631.
16. Dunker, A. K., Brown, C. J., Lawson, J. D., Iakoucheva, L. M., & Obradović, Z. (2002). Intrinsic disorder and protein function. Biochemistry, 41(21), 6573-6582.
17. Gsponer, J., & Babu, M. M. (2009). The rules of disorder or why disorder rules. Progress in biophysics and molecular biology, 99(2-3), 94-103.
18. Tompa P. (2002). Intrinsically unstructured proteins. Trends in biochemical sciences, 27(10), 527–533. https://doi.org/10.1016/s0968-0004(02)02169-2
19. Tompa, P. (2005). The interplay between structure and function in intrinsically unstructured proteins. FEBS letters, 579(15), 3346-3354.
20. Piai, A., Calçada, E. O., Tarenzi, T., del Grande, A., Varadi, M., Tompa, P., ... & Pierattelli, R. (2016). Just a flexible linker? The structural and dynamic properties of CBP-ID4 revealed by NMR spectroscopy. Biophysical journal, 110(2), 372-381.
21. Nagy, A., Grama, L., Huber, T., Bianco, P., Trombitas, K., Granzier, H. L., & Kellermayer, M. S. Z. (2005). Hierarchical extensibility in the PEVK domain of skeletal-muscle titin. Biophysical Journal, 89(1), 329-336.
22. Dunker, A. K., Silman, I., Uversky, V. N., & Sussman, J. L. (2008). Function and structure of inherently disordered proteins. Current opinion in structural biology, 18(6), 756-764.
23. Iakoucheva, L. M., Radivojac, P., Brown, C. J., O’Connor, T. R., Sikes, J. G., Obradovic, Z., & Dunker, A. K. (2004). The importance of intrinsic disorder for protein phosphorylation. Nucleic acids research, 32(3), 1037-1049.
24. Collins, M. O., Yu, L., Campuzano, I., Grant, S. G., & Choudhary, J. S. (2008). Phosphoproteomic analysis of the mouse brain cytosol reveals a predominance of protein phosphorylation in regions of intrinsic sequence disorder. Molecular & Cellular Proteomics, 7(7), 1331-1348.
25. Holt, L. J., Tuch, B. B., Villén, J., Johnson, A. D., Gygi, S. P., & Morgan, D. O. (2009). Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution. Science, 325(5948), 1682-1686.
26. Wright, P. E., & Dyson, H. J. (1999). Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. Journal of molecular biology, 293(2), 321- 331.
27. Dyson, H. J., & Wright, P. E. (2005). Intrinsically unstructured proteins and their functions. Nature reviews Molecular cell biology, 6(3), 197-208.
28. Oldfield, C. J., Cheng, Y., Cortese, M. S., Romero, P., Uversky, V. N., & Dunker, A. K. (2005). Coupled folding and binding with α-helix-forming molecular recognition elements. Biochemistry, 44(37), 12454-12470.
29. Iakoucheva, L. M., Brown, C. J., Lawson, J. D., Obradović, Z., & Dunker, A. K. (2002). Intrinsic disorder in cell-signaling and cancer-associated proteins. Journal of molecular biology, 323(3), 573-584.
30. Whitley, D., Goldberg, S. P., & Jordan, W. D. (1999). Heat shock proteins: a review of the molecular chaperones. Journal of vascular surgery, 29(4), 748-751.
31. Bardwell, J. C., & Jakob, U. (2012). Conditional disorder in chaperone action. Trends in biochemical sciences, 37(12), 517-525.
32. Tompa, P., & Csermely, P. (2004). The role of structural disorder in the function of RNA and protein chaperones. The FASEB Journal, 18(11), 1169-1175.
33. Tompa, P., & Kovacs, D. (2010). Intrinsically disordered chaperones in plants and animals. Biochemistry and Cell Biology, 88(2), 167-174.
34. Tsai, C. J., Kumar, S., Ma, B., & Nussinov, R. (1999). Folding funnels, binding funnels, and protein function. Protein Science, 8(6), 1181-1190.
35. Levy, Y., Cho, S. S., Onuchic, J. N., & Wolynes, P. G. (2005). A survey of flexible protein binding mechanisms and their transition states using native topology based energy landscapes. Journal of molecular biology, 346(4), 1121-1145.
36. Sugase, K., Dyson, H. J., & Wright, P. E. (2007). Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature, 447(7147), 1021-1025.
37. Diella, F., Haslam, N., Chica, C., Budd, A., Michael, S., Brown, N. P., ... & Gibson, T. J. (2008). Understanding eukaryotic linear motifs and their role in cell signaling and regulation. Front Biosci, 13(6580), 603.
38. Hegyi, H., Schad, E., & Tompa, P. (2007). Structural disorder promotes assembly of protein complexes. BMC structural biology, 7(1), 65.
39. Liu, Z., & Huang, Y. (2014). Advantages of proteins being disordered. Protein Science, 23(5), 539-550.
40. Shajani, Z., Sykes, M. T., & Williamson, J. R. (2011). Assembly of bacterial ribosomes. Annual review of biochemistry, 80, 501-526.
41. Xue, B., Romero, P. R., Noutsou, M., Maurice, M. M., Rüdiger, S. G., William Jr, A. M., ... & Dunker, A. K. (2013). Stochastic machines as a colocalization mechanism for scaffold protein function. FEBS letters, 587(11), 1587-1591.
42. Daniels, A. J., Williams, R. J. P., & Wright, P. E. (1978). The character of the stored molecules in chromaffin granules of the adrenal medulla: a nuclear magnetic resonance study. Neuroscience, 3(6), 573-585.
43. Holt, C., Carver, J. A., Ecroyd, H., & Thorn, D. C. (2013). Invited review: Caseins and the casein micelle: Their biological functions, structures, and behavior in foods. Journal of dairy science, 96(10), 6127-6146.
44. Davey, N. E., Van Roey, K., Weatheritt, R. J., Toedt, G., Uyar, B., Altenberg, B., ... & Gibson, T. J. (2012). Attributes of short linear motifs. Molecular BioSystems, 8(1), 268-281.
45. Kalderon, D., Roberts, B. L., Richardson, W. D., & Smith, A. E. (1984). A short amino acid sequence able to specify nuclear location. Cell, 39(3), 499-509.
46. Dyson, H. J. (2011). Expanding the proteome: disordered and alternatively folded proteins. Quarterly reviews of biophysics, 44(4), 467-518.
47. Remaut, H., & Waksman, G. (2006). Protein–protein interaction through β-strand addition. Trends in biochemical sciences, 31(8), 436-444.
48. Donaldson, L. W., Gish, G., Pawson, T., Kay, L. E., & Forman-Kay, J. D. (2002). Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. Proceedings of the National Academy of Sciences, 99(22), 14053-14058.
49. Van Roey, K., Uyar, B., Weatheritt, R. J., Dinkel, H., Seiler, M., Budd, A., ... & Davey, N. E. (2014). Short linear motifs: ubiquitous and functionally diverse protein interaction modules directing cell regulation. Chemical reviews, 114(13), 6733-6778.
50. Fischer, U., Jänicke, R. U., & Schulze-Osthoff, K. (2003). Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death & Differentiation, 10(1), 76- 100.
51. Davey, N. E., Travé, G., & Gibson, T. J. (2011). How viruses hijack cell regulation. Trends in biochemical sciences, 36(3), 159-169.
52. Jürgens, M. C., Vörös, J., Rautureau, G. J., Shepherd, D. A., Pye, V. E., Muldoon, J., ... & Ferguson, N. (2013). The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry. Nature chemical biology, 9(9), 540-547.
53. Hazy, E., & Tompa, P. (2009). Limitations of induced folding in molecular recognition by intrinsically disordered proteins. Chemphyschem, 10(9‐10), 1415- 1419.
54. Burgen, A. S. V., Roberts, G. C. K., & Feeney, J. (1975). Binding of flexible ligands to macromolecules. Nature, 253(5494), 753-755.
55. Tompa, P., Fuxreiter, M., Oldfield, C. J., Simon, I., Dunker, A. K., & Uversky, V. N. (2009). Close encounters of the third kind: disordered domains and the interactions of proteins. Bioessays, 31(3), 328-335.
56. Buljan, M., Frankish, A., & Bateman, A. (2010). Quantifying the mechanisms of domain gain in animal proteins. Genome biology, 11(7), 1-15.
57. Chen, J. W., Romero, P., Uversky, V. N., & Dunker, A. K. (2006). Conservation of intrinsic disorder in protein domains and families: II. functions of conserved disorder. Journal of proteome research, 5(4), 888-898.
58. Dyson, H. J., & Wright, P. E. (1998). Equilibrium NMR studies of unfolded and partially folded proteins. nature structural biology, 5(7), 499-503.
59. Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M., Romero, P., Oh, J. S., ... & Ausio, J. (2001). Intrinsically disordered protein. Journal of molecular graphics and modelling, 19(1), 26-59.
60. Tompa, P. (2012). On the supertertiary structure of proteins. Nature chemical biology, 8(7), 597-600.
61. Meyer, U. A. (2000). Pharmacogenetics and adverse drug reactions. The Lancet, 356(9242), 1667-1671.
62. Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005). Multicomponent therapeutics for networked systems. Nature reviews Drug discovery, 4(1), 71-78.
63. Metallo, S. J. (2010). Intrinsically disordered proteins are potential drug targets. Current opinion in chemical biology, 14(4), 481-488.
64. Vavouri, T., Semple, J. I., Garcia-Verdugo, R., & Lehner, B. (2009). Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell, 138(1), 198-208.
65. Gsponer, J., Futschik, M. E., Teichmann, S. A., & Babu, M. M. (2008). Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science, 322(5906), 1365-1368.
66. Dunker, A. K., Garner, E., Guilliot, S., Romero, P., Albrecht, K., Hart, J., ... & Villafranca, J. E. (1998, August). Protein disorder and the evolution of molecular recognition: theory, predictions and observations. In Pac Symp Biocomput (Vol. 3, pp. 473-484).
67. Shaiu, W. L., Hu, T., & Hsieh, T. S. (1999). The hydrophilic, proteas e-sensitive terminal domains of eucaryotic dna topoisomerases have essential intracellular functions. In Biocomputing'99 (pp. 578-589).
68. Sayers, E. W., Gerstner, R. B., Draper, D. E., & Torchia, D. A. (2000). Structural preordering in the N-terminal region of ribosomal protein S4 revealed by heteronuclear NMR spectroscopy. Biochemistry, 39(44), 13602-13613.
69. Wissmann, R., Baukrowitz, T., Kalbacher, H., Kalbitzer, H. R., Ruppersberg, J. P., Pongs, O., ... & Fakler, B. (1999). NMR structure and functional characteristics of the hydrophilic N terminus of the potassium channel β-subunit Kvβ1. 1. Journal of Biological Chemistry, 274(50), 35521-35525.
70. Brown, C. J., Takayama, S., Campen, A. M., Vise, P., Marshall, T. W., Oldfield, C. J., ... & Dunker, A. K. (2002). Evolutionary rate heterogeneity in proteins with long disordered regions. Journal of molecular evolution, 55(1), 104-110.
71. Vonderviszt, F., Kanto, S., Aizawa, S. I., & Namba, K. (1989). Terminal regions of flagellin are disordered in solution. Journal of molecular biology, 209(1), 127-133.
72. Dunker, A. K., Oldfield, C. J., Meng, J., Romero, P., Yang, J. Y., Chen, J. W., ... & Uversky, V. N. (2008). The unfoldomics decade: an update on intrinsically disordered proteins. BMC genomics, 9(2), 1-26.
73. Brown, C. J., Johnson, A. K., Dunker, A. K., & Daughdrill, G. W. (2011). Evolution and disorder. Current opinion in structural biology, 21(3), 441-446.
74. Wilke, C. O., & Drummond, D. A. (2010). Signatures of protein biophysics in coding sequence evolution. Current opinion in structural biology, 20(3), 385-389.
2.7 References
1. Uversky, V. N., Gillespie, J. R., & Fink, A. L. (2000). Why are “natively unfolded” proteins unstructured under physiologic conditions?. Proteins: structure, function, and bioinformatics, 41(3), 415-427.
2. Romero, P., Obradovic, Z., Li, X., Garner, E. C., Brown, C. J., & Dunker, A. K. (2001). Sequence complexity of disordered protein. Proteins: Structure, Function, and Bioinformatics, 42(1), 38-48.
3. Dunker, A. K., Oldfield, C. J., Meng, J., Romero, P., Yang, J. Y., Chen, J. W., ... & Uversky, V. N. (2008). The unfoldomics decade: an update on intrinsically disordered proteins. BMC genomics, 9(2), 1-26.
4. Dunker, A. K., Brown, C. J., Lawson, J. D., Iakoucheva, L. M., & Obradović, Z. (2002). Intrinsic disorder and protein function. Biochemistry, 41(21), 6573-6582.
5. Wright, P. E., & Dyson, H. J. (2015). Intrinsically disordered proteins in cellular signalling and regulation. Nature reviews Molecular cell biology, 16(1), 18-29.
6. Romero, P., Obradovic, Z., Li, X., Garner, E. C., Brown, C. J., & Dunker, A. K. (2001). Sequence complexity of disordered protein. Proteins: Structure, Function, and Bioinformatics, 42(1), 38-48.
7. Brown, C. J., Takayama, S., Campen, A. M., Vise, P., Marshall, T. W., Oldfield, C. J., ... & Dunker, A. K. (2002). Evolutionary rate heterogeneity in proteins with long disordered regions. Journal of molecular evolution, 55(1), 104-110.
8. Besson, A., Dowdy, S. F., & Roberts, J. M. (2008). CDK inhibitors: cell cycle regulators and beyond. Developmental cell, 14(2), 159-169.
9. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., & Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75(4), 805-816.
10. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., ... & Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell, 75(4), 817-825.
11. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994). p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factorbeta and contact inhibition to cell cycle arrest. Genes & development, 8(1), 9-22.
12. Sherr, C. J., & Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes & development, 13(12), 1501-1512.
13. Adkins, J. N., & Lumb, K. J. (2002). Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2. Proteins: Structure, Function, and Bioinformatics, 46(1), 1-7.
14. Esteve, V., Canela, N., Rodriguez‐Vilarrupla, A., Aligué, R., Agell, N., Mingarro, I., ... & Pérez‐Payá, E. (2003). The structural plasticity of the C terminus of p21Cip1 is a determinant for target protein recognition. Chembiochem, 4(9), 863-869.
15. Lacy, E. R., Filippov, I., Lewis, W. S., Otieno, S., Xiao, L., Weiss, S., ... & Kriwacki, R. W. (2004). p27 binds cyclin–CDK complexes through a sequential mechanism involving binding-induced protein folding. Nature structural & molecular biology, 11(4), 358-364.
16. Kriwacki, R. W., Hengst, L., Tennant, L., Reed, S. I., & Wright, P. E. (1996). Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proceedings of the National Academy of Sciences, 93(21), 11504-11509.
17. Sivakolundu, S. G., Bashford, D., & Kriwacki, R. W. (2005). Disordered p27Kip1 exhibits intrinsic structure resembling the Cdk2/cyclin A-bound conformation. Journal of molecular biology, 353(5), 1118-1128.
18. Watanabe, H., Pan, Z. Q., Schreiber-Agus, N., DePinho, R. A., Hurwitz, J., & Xiong, Y. (1998). Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proceedings of the National Academy of Sciences, 95(4), 1392-1397.
19. Nakayama, K. I., & Nakayama, K. (1998). Cip/Kip cyclin‐dependent kinase inhibitors: brakes of the cell cycle engine during development. Bioessays, 20(12), 1020-1029.
20. Chen, I. T., Akamatsu, M., Smith, M. L., Lung, F. D., Duba, D., Roller, P. P., ... & O'Connor, P. M. (1996). Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene, 12(3), 595-607.
21. Itoh, Y., Masuyama, N., Nakayama, K., Nakayama, K. I., & Gotoh, Y. (2007). The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex. Journal of Biological Chemistry, 282(1), 390-396.
22. Chang, T. S., Kim, M. J., Ryoo, K., Park, J., Eom, S. J., Shim, J., ... & Lee, M. J. (2003). p57KIP2 modulates stress-activated signaling by inhibiting c-Jun NH2- terminal kinase/stress-activated protein Kinase. Journal of Biological Chemistry, 278(48), 48092-48098.
23. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990). Basic local alignment search tool. Journal of molecular biology, 215(3), 403-410.
24. Pruitt, K. D., Tatusova, T., & Maglott, D. R. (2005). NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic acids research, 33(suppl_1), D501-D504.
25. Katoh, K., Misawa, K., Kuma, K. I., & Miyata, T. (2002). MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic acids research, 30(14), 3059-3066.
26. Kumar, S., Stecher, G., & Tamura, K. (2016). MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Molecular biology and evolution, 33(7), 1870-1874.
27. Ronquist, F., Teslenko, M., Van Der Mark, P., Ayres, D. L., Darling, A., Höhna, S., ... & Huelsenbeck, J. P. (2012). MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space. Systematic biology, 61(3), 539-542.
28. Miller, M. A., Pfeiffer, W., & Schwartz, T. (2011, July). The CIPRES science gateway: a community resource for phylogenetic analyses. In Proceedings of the 2011 TeraGrid Conference: extreme digital discovery (pp. 1-8).
29. Tanabe, A. S. (2011). Kakusan4 and Aminosan: two programs for comparing nonpartitioned, proportional and separate models for combined molecular phylogenetic analyses of multilocus sequence data. Molecular Ecology Resources, 11(5), 914-921.
30. Dosztányi, Z., Csizmok, V., Tompa, P., & Simon, I. (2005). IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics, 21(16), 3433-3434.
31. Fuxreiter, M., Tompa, P., & Simon, I. (2007). Local structural disorder imparts plasticity on linear motifs. Bioinformatics, 23(8), 950-956.
32. Drozdetskiy, A., Cole, C., Procter, J., & Barton, G. J. (2015). JPred4: a protein secondary structure prediction server. Nucleic acids research, 43(W1), W389-W394.
33. Letunic, I., & Bork, P. (2016). Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic acids research, 44(W1), W242-W245.
34. Blom, N., Gammeltoft, S., & Brunak, S. (1999). Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. Journal of molecular biology, 294(5), 1351-1362.
35. Pupko, T., Bell, R. E., Mayrose, I., Glaser, F., & Ben-Tal, N. (2002). Rate4Site: an algorithmic tool for the identification of functional regions in proteins by surface mapping of evolutionary determinants within their homologues. Bioinformatics, 18(suppl_1), S71-S77.
36. Cohen, O., Ashkenazy, H., Belinky, F., Huchon, D., & Pupko, T. (2010). GLOOME: gain loss mapping engine. Bioinformatics, 26(22), 2914-2915.
37. Hornbeck, P. V., Zhang, B., Murray, B., Kornhauser, J. M., Latham, V., & Skrzypek, E. (2015). PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic acids research, 43(D1), D512-D520.
38. Fahmi, M., & Ito, M. (2019). Evolutionary approach of intrinsically disordered CIP/KIP proteins. Scientific reports, 9(1), 1-10.
39. Xie, Q., Obradovic, Z., Arnold, G. E., Garner, E., Romero, P., & Dunker, A. K. (1998). The sequence attribute method for determining relationships between sequence and protein disorder. Genome Informatics, 9, 193-200.
40. Williams, R. M., Obradovic, Z., Mathura, V., Braun, W., Garner, E. C., Young, J., ... & Dunker, A. K. (2000). The protein non-folding problem: amino acid determinants of intrinsic order and disorder. In Biocomputing 2001 (pp. 89-100).
41. Malumbres, M., & Barbacid, M. (2005). Mammalian cyclin-dependent kinases. Trends in biochemical sciences, 30(11), 630-641.
42. Brown, C. J., Johnson, A. K., Dunker, A. K., & Daughdrill, G. W. (2011). Evolution and disorder. Current opinion in structural biology, 21(3), 441-446.
43. Van Der Lee, R., Buljan, M., Lang, B., Weatheritt, R. J., Daughdrill, G. W., Dunker, A. K., ... & Kim, P. M. (2014). Classification of intrinsically disordered regions and proteins. Chemical reviews, 114(13), 6589-6631.
44. Matsuoka, S., Thompson, J. S., Edwards, M. C., Bartletta, J. M., Grundy, P., Kalikin, L. M., ... & Feinberg, A. P. (1996). Imprinting of the gene encoding a human cyclindependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proceedings of the National Academy of Sciences, 93(7), 3026-3030.
3.7 References
1. Rett, A. (1966). On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wiener medizinische Wochenschrift (1946), 116(37), 723.
2. Hanefeld, F. (1985). The clinical pattern of the Rett syndrome. Brain & development, 7(3), 320-325.
3. Lyst, M. J., Ekiert, R., Ebert, D. H., Merusi, C., Nowak, J., Selfridge, J., ... & Rappsilber, J. (2013). Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nature neuroscience, 16(7), 898.
4. Lyst, M. J., & Bird, A. (2015). Rett syndrome: a complex disorder with simple roots. Nature Reviews Genetics, 16(5), 261-275.
5. Tillotson, R., Selfridge, J., Koerner, M. V., Gadalla, K. K., Guy, J., De Sousa, D., ... & Bird, A. (2017). Radically truncated MeCP2 rescues Rett syndrome-like neurological defects. Nature, 550(7676), 398-401.
6. Trappe, R., Laccone, F., Cobilanschi, J., Meins, M., Huppke, P., Hanefeld, F., & Engel, W. (2001). MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. The American Journal of Human Genetics, 68(5), 1093-1101.
7. Van Esch, H., Bauters, M., Ignatius, J., Jansen, M., Raynaud, M., Hollanders, K., ... & Moraine, C. (2005). Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. The American Journal of Human Genetics, 77(3), 442-453.
8. Neul, J. L. (2012). The relationship of Rett syndrome and MECP2 disorders to autism. Dialogues in clinical neuroscience, 14(3), 253.
9. Ghosh, R. P., Nikitina, T., Horowitz-Scherer, R. A., Gierasch, L. M., Uversky, V. N., Hite, K., ... & Woodcock, C. L. (2010). Unique physical properties and interactions of the domains of methylated DNA binding protein 2. Biochemistry, 49(20), 4395-4410.
10. Toth-Petroczy, A., Palmedo, P., Ingraham, J., Hopf, T. A., Berger, B., Sander, C., & Marks, D. S. (2016). Structured states of disordered proteins from genomic sequences. Cell, 167(1), 158-170.
11. Canning, P., Park, K., Gonçalves, J., Li, C., Howard, C. J., Sharpe, T. D., ... & Leroux, M. R. (2018). CDKL family kinases have evolved distinct structural features and ciliary function. Cell reports, 22(4), 885-894.
12. Uversky, V. N., Gillespie, J. R., & Fink, A. L. (2000). Why are “natively unfolded” proteins unstructured under physiologic conditions?. Proteins: structure, function, and bioinformatics, 41(3), 415-427.
13. Romero, P., Obradovic, Z., Li, X., Garner, E. C., Brown, C. J., & Dunker, A. K. (2001). Sequence complexity of disordered protein. Proteins: Structure, Function, and Bioinformatics, 42(1), 38-48.
14. Dunker, A. K., Oldfield, C. J., Meng, J., Romero, P., Yang, J. Y., Chen, J. W., ... & Uversky, V. N. (2008). The unfoldomics decade: an update on intrinsically disordered proteins. BMC genomics, 9(2), 1-26.
15. Diella, F., Haslam, N., Chica, C., Budd, A., Michael, S., Brown, N. P., ... & Gibson, T. J. (2008). Understanding eukaryotic linear motifs and their role in cell signaling and regulation. Front Biosci, 13(6580), 603.
16. Galea, C. A., Wang, Y., Sivakolundu, S. G., & Kriwacki, R. W. (2008). Regulation of cell division by intrinsically unstructured proteins: intrinsic flexibility, modularity, and signaling conduits. Biochemistry, 47(29), 7598-7609.
17. Van Der Lee, R., Buljan, M., Lang, B., Weatheritt, R. J., Daughdrill, G. W., Dunker, A. K., ... & Kim, P. M. (2014). Classification of intrinsically disordered regions and proteins. Chemical reviews, 114(13), 6589-6631.
18. Fahmi, M., & Ito, M. (2019). Evolutionary approach of intrinsically disordered CIP/KIP proteins. Scientific reports, 9(1), 1-10.
19. Sato, Y., Nakaya, A., Shiraishi, K., Kawashima, S., Goto, S., & Kanehisa, M. (2001). Ssdb: Sequence similarity database in kegg. Genome Informatics, 12, 230-231.
20. Katoh, K., & Standley, D. M. (2013). MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Molecular biology and evolution, 30(4), 772-780.
21. Stamatakis, A. (2006). RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics, 22(21), 2688-2690.
22. Darriba, D., Posada, D., Kozlov, A. M., Stamatakis, A., Morel, B., & Flouri, T. (2020). ModelTest-NG: a new and scalable tool for the selection of DNA and protein evolutionary models. Molecular biology and evolution, 37(1), 291-294.
23. Federhen, S. (2012). The NCBI taxonomy database. Nucleic acids research, 40(D1), D136-D143.
24. Miller, M. A., Pfeiffer, W., & Schwartz, T. (2010, November). Creating the CIPRES Science Gateway for inference of large phylogenetic trees. In 2010 gateway computing environments workshop (GCE) (pp. 1-8). Ieee.
25. Mészáros, B., Erdős, G., & Dosztányi, Z. (2018). IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding. Nucleic acids research, 46(W1), W329-W337.
26. Letunic, I., & Bork, P. (2007). Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics, 23(1), 127-128.
27. Pupko, T., Bell, R. E., Mayrose, I., Glaser, F., & Ben-Tal, N. (2002). Rate4Site: an algorithmic tool for the identification of functional regions in proteins by surface mapping of evolutionary determinants within their homologues. Bioinformatics, 18(suppl_1), S71-S77.
28. Blom, N., Gammeltoft, S., & Brunak, S. (1999). Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. Journal of molecular biology, 294(5), 1351-1362.
29. Krishnaraj, R., Ho, G., & Christodoulou, J. (2017). RettBASE: Rett syndrome database update. Human mutation, 38(8), 922-931.
30. Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., ... & Tukiainen, T. (2016). Analysis of protein-coding genetic variation in 60,706 humans. Nature, 536(7616), 285-291.
31. Chatr-Aryamontri, A., Oughtred, R., Boucher, L., Rust, J., Chang, C., Kolas, N. K., ... & Stark, C. (2017). The BioGRID interaction database: 2017 update. Nucleic acids research, 45(D1), D369-D379.
32. UniProt Consortium. (2010). The universal protein resource (UniProt) in 2010. Nucleic acids research, 38(suppl_1), D142-D148.
33. Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., & Morishima, K. (2017). KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic acids research, 45(D1), D353-D361.
34. Ward Jr, J. H. (1963). Hierarchical grouping to optimize an objective function. Journal of the American statistical association, 58(301), 236-244.
35. Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., ... & Olsson, I. (2015). Tissue-based map of the human proteome. Science, 347(6220).
36. Mi, H., Muruganujan, A., Ebert, D., Huang, X., & Thomas, P. D. (2019). PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic acids research, 47(D1), D419-D426.
37. Grimmler, M., Wang, Y., Mund, T., Cilenšek, Z., Keidel, E. M., Waddell, M. B., ... & Hengst, L. (2007). Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell, 128(2), 269-280.
38. Gsponer, J., Futschik, M. E., Teichmann, S. A., & Babu, M. M. (2008). Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science, 322(5906), 1365-1368.
39. Fahmi, M., Yasui, G., Seki, K., Katayama, S., Kaneko-Kawano, T., Inazu, T., ... & Ito, M. (2019). In silico study of rett syndrome treatment-related genes, mecp2, cdkl5, and foxg1, by evolutionary classification and disordered region assessment. International journal of molecular sciences, 20(22), 5593.
40. Guy, J., Alexander-Howden, B., FitzPatrick, L., DeSousa, D., Koerner, M. V., Selfridge, J., & Bird, A. (2018). A mutation-led search for novel functional domains in MeCP2. Human molecular genetics, 27(14), 2531-2545.
41. Ballestar, E., Yusufzai, T. M., & Wolffe, A. P. (2000). Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry, 39(24), 7100-7106.
42. Yusufzai, T. M., & Wolffe, A. P. (2000). Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic acids research, 28(21), 4172- 4179.
43. Mnatzakanian, G. N., Lohi, H., Munteanu, I., Alfred, S. E., Yamada, T., MacLeod, P. J., ... & Vincent, J. B. (2004). A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nature genetics, 36(4), 339-341.
44. Williamson, S. L., Giudici, L., Kilstrup-Nielsen, C., Gold, W., Pelka, G. J., Tam, P. P., ... & Christodoulou, J. (2012). A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain. Human genetics, 131(2), 187-200.
45. Payankaulam, S., Li, L. M., & Arnosti, D. N. (2010). Transcriptional repression: conserved and evolved features. Current biology, 20(17), R764-R771.
46. Wong, L. C., Singh, S., Wang, H. P., Hsu, C. J., Hu, S. C., & Lee, W. T. (2019). FOXG1-Related Syndrome: From Clinical to Molecular Genetics and Pathogenic Mechanisms. International journal of molecular sciences, 20(17), 4176.
47. Toresson, H., Martinez-Barbera, J. P., Bardsley, A., Caubit, X., & Krauss, S. (1998). Conservation of BF-1 expression in amphioxus and zebrafish suggests evolutionary ancestry of anterior cell types that contribute to the vertebrate telencephalon. Development genes and evolution, 208(8), 431-439.
48. Mari, F., Azimonti, S., Bertani, I., Bolognese, F., Colombo, E., Caselli, R., ... & Ariani, F. (2005). CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Human molecular genetics, 14(14), 1935-1946.
49. Livide, G., Patriarchi, T., Amenduni, M., Amabile, S., Yasui, D., Calcagno, E., ... & Mari, F. (2015). GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells. European Journal of Human Genetics, 23(2), 195-201.
50. Carouge, D., Host, L., Aunis, D., Zwiller, J., & Anglard, P. (2010). CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiology of disease, 38(3), 414-424.
51. Bertani, I., Rusconi, L., Bolognese, F., Forlani, G., Conca, B., De Monte, L., ... & Kilstrup-Nielsen, C. (2006). Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation. Journal of Biological Chemistry, 281(42), 32048-32056.
52. Rusconi, L., Salvatoni, L., Giudici, L., Bertani, I., Kilstrup-Nielsen, C., Broccoli, V., & Landsberger, N. (2008). CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. Journal of Biological Chemistry, 283(44), 30101-30111.
53. Van Roey, K., Uyar, B., Weatheritt, R. J., Dinkel, H., Seiler, M., Budd, A., ... & Davey, N. E. (2014). Short linear motifs: ubiquitous and functionally diverse protein interaction modules directing cell regulation. Chemical reviews, 114(13), 6733-6778.
4.7 References
1. Schwarz, F., & Aebi, M. (2011). Mechanisms and principles of N-linked protein glycosylation. Current opinion in structural biology, 21(5), 576-582.
2. Varki, A., Freeze, H. H., & Gagneux, P. (2009). Evolution of glycan diversity. In Essentials of Glycobiology. 2nd edition. Cold Spring Harbor Laboratory Press.
3. Day, A. J., & Prestwich, G. D. (2002). Hyaluronan-binding proteins: tying up the giant. Journal of Biological Chemistry, 277(7), 4585-4588.
4. Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999). Functions of cell surface heparan sulfate proteoglycans. Annual review of biochemistry, 68(1), 729-777.
5. Li, M., Song, L., & Qin, X. (2010). Glycan changes: cancer metastasis and anticancer vaccines. Journal of biosciences, 35(4), 665-673.
6. Tomono, T., Kojima, H., Fukuchi, S., Tohsato, Y., & Ito, M. (2015). Investigation of glycan evolution based on a comprehensive analysis of glycosyltransferases using phylogenetic profiling. Biophysics and physicobiology, 12, 57-68.
7. Lombard, V., Golaconda Ramulu, H., Drula, E., Coutinho, P. M., & Henrissat, B. (2014). The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic acids research, 42(D1), D490-D495.
8. Placzek, S., Schomburg, I., Chang, A., Jeske, L., Ulbrich, M., Tillack, J., & Schomburg, D. (2016). BRENDA in 2017: new perspectives and new tools in BRENDA. Nucleic acids research, gkw952.
9. Hunter, S., Apweiler, R., Attwood, T. K., Bairoch, A., Bateman, A., Binns, D., ... & Finn, R. D. (2009). InterPro: the integrative protein signature database. Nucleic acids research, 37(suppl_1), D211-D215.
10. Botstein, D., Cherry, J. M., Ashburner, M., Ball, C. A., Blake, J. A., Butler, H., ... & Eppig, J. T. (2000). Gene Ontology: tool for the unification of biology. Nat genet, 25(1), 25-9.
11. Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., & Morishima, K. (2017). KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic acids research, 45(D1), D353-D361.
12. Ward Jr, J. H. (1963). Hierarchical grouping to optimize an objective function. Journal of the American statistical association, 58(301), 236-244.
13. Nakamura, T., Fahmi, M., Tanaka, J., Seki, K., Kubota, Y., & Ito, M. (2019). Genome-wide analysis of whole human glycoside hydrolases by data-driven analysis in silico. International journal of molecular sciences, 20(24), 6290.
14. Mészáros, B., Erdős, G., & Dosztányi, Z. (2018). IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding. Nucleic acids research, 46(W1), W329-W337.
15. Oates, M. E., Romero, P., Ishida, T., Ghalwash, M., Mizianty, M. J., Xue, B., ... & Dunker, A. K. (2012). D2P2: database of disordered protein predictions. Nucleic acids research, 41(D1), D508-D516.
16. Marin, M. B., Ghenea, S., Spiridon, L. N., Chiritoiu, G. N., Petrescu, A. J., & Petrescu, S. M. (2012). Tyrosinase degradation is prevented when EDEM1 lacks the intrinsically disordered region. PloS one, 7(8), e42998.
17. Olivari, S., & Molinari, M. (2007). Glycoprotein folding and the role of EDEM1, EDEM2 and EDEM3 in degradation of folding-defective glycoproteins. FEBS letters, 581(19), 3658-3664.
18. Fahmi, M., & Ito, M. (2019). Evolutionary approach of intrinsically disordered CIP/KIP proteins. Scientific reports, 9(1), 1-10.
19. Fahmi, M., Yasui, G., Seki, K., Katayama, S., Kaneko-Kawano, T., Inazu, T., ... & Ito, M. (2019). In silico study of rett syndrome treatment-related genes, mecp2, cdkl5, and foxg1, by evolutionary classification and disordered region assessment. International journal of molecular sciences, 20(22), 5593.
20. Van Der Lee, R., Buljan, M., Lang, B., Weatheritt, R. J., Daughdrill, G. W., Dunker, A. K., ... & Kim, P. M. (2014). Classification of intrinsically disordered regions and proteins. Chemical reviews, 114(13), 6589-6631.
論文の公開元へ
